Paper2805409
Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis.
Macpherson JL and 8 others. Clin Exp Immunol, 1989. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis. Papers, record 2805409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2805409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Platelet Activating Factor | Major topic |
| Platelet Aggregation Inhibitors | Major topic |
| Urticaria Pigmentosa | Major topic |
| Blister | |
| Humans | |
| Infant, Newborn | |
| Male |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 72725 | Release of platelet-activating factor and histamine. I. Effect of immune complexes, complement and neutrophils on human and rabbit mastocytes and basophils. | Immunology | 1977 | https://conductscience.org/library/papers/72725 | PubMed |
| 2 | 17941181 | Release, purification, and characterization of platelet-activating factor (PAF). | Biochimie | 1980 | https://conductscience.org/library/papers/17941181 | PubMed |
| 3 | 6107852 | Increased production of prostaglandin D2 in patients with systemic mastocytosis. | N Engl J Med | 1980 | https://conductscience.org/library/papers/6107852 | PubMed |
| 4 | 7037068 | Effect of platelet-activating factor (PAF) on human platelets. | Blood | 1982 | https://conductscience.org/library/papers/7037068 | PubMed |
| 5 | 7067099 | Rapid assay for amino acids in serum or urine by pre-column derivatization and reversed-phase liquid chromatography. | Clin Chem | 1982 | https://conductscience.org/library/papers/7067099 | PubMed |
| 6 | 6819153 | Cromoglycate (DSCG) inhibits responses to platelet-activating factor (PAF-acether) in man: an alternative mode of action for DSCG in asthma? | Eur J Pharmacol | 1982 | https://conductscience.org/library/papers/6819153 | PubMed |
| 7 | 6646186 | Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites. | N Engl J Med | 1983 | https://conductscience.org/library/papers/6646186 | PubMed |
| 8 | 6481248 | High performance liquid chromatography of platelet-activating factors. | J Lipid Res | 1984 | https://conductscience.org/library/papers/6481248 | PubMed |
| 9 | 6387670 | Bullous mastocytosis: diffuse cutaneous mastocytosis with extensive blisters mimicking scalded skin syndrome or erythema multiforme. | Pediatr Dermatol | 1984 | https://conductscience.org/library/papers/6387670 | PubMed |
| 10 | 3978036 | Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in man. | Br J Dermatol | 1985 | https://conductscience.org/library/papers/3978036 | PubMed |
| 11 | 4003196 | Suppression of Paf-acether responses: an anti-inflammatory effect of anti-asthma drugs. | Agents Actions | 1985 | https://conductscience.org/library/papers/4003196 | PubMed |
| 12 | 3864190 | Metabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis. | Prostaglandins | 1985 | https://conductscience.org/library/papers/3864190 | PubMed |
| 13 | 3002327 | Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP. | Biochem J | 1985 | https://conductscience.org/library/papers/3002327 | PubMed |
| 14 | 3083731 | Effects of ketotifen upon responses to platelet activating factor: a basis for asthma prophylaxis. | Ann Allergy | 1986 | https://conductscience.org/library/papers/3083731 | PubMed |
| 15 | 3085750 | Substrate for endothelial prostacyclin production in the presence of platelets exposed to collagen is derived from the platelets rather than the endothelium. | Blood | 1986 | https://conductscience.org/library/papers/3085750 | PubMed |
| 16 | 3018086 | Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. | J Invest Dermatol | 1986 | https://conductscience.org/library/papers/3018086 | PubMed |
| 17 | 3804997 | Occurrence of an endogenous inhibitor of platelet-activating factor in rat liver. | J Biol Chem | 1987 | https://conductscience.org/library/papers/3804997 | PubMed |
| 18 | 2963750 | Ketotifen inhibits paf-acether biosynthesis and beta-hexosaminidase release in mouse mast cells stimulated with antigen. | Eur J Pharmacol | 1987 | https://conductscience.org/library/papers/2963750 | PubMed |
| 19 | 2898694 | Treatment of adult systemic mastocytosis with a PAF-acether antagonist BN52063. | Lancet | 1988 | https://conductscience.org/library/papers/2898694 | PubMed |
| 20 | 13671378 | A rapid method of total lipid extraction and purification. | Can J Biochem Physiol | 1959 | https://conductscience.org/library/papers/13671378 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37108232 | Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108232 | PubMed |
| 33806685 | Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33806685 | PubMed |
| 31816871 | Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives. | Molecules | 2019 | https://conductscience.org/library/papers/31816871 | PubMed |
| 30770937 | Multiple vertebral fractures as the first manifestation of systemic mastocytosis. | Osteoporos Int | 2019 | https://conductscience.org/library/papers/30770937 | PubMed |
| 26892042 | Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis. | Osteoporos Int | 2016 | https://conductscience.org/library/papers/26892042 | PubMed |
| 21668033 | Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations. | Am J Clin Dermatol | 2011 | https://conductscience.org/library/papers/21668033 | PubMed |
| 1819737 | Platelet-activating factor type activity in plasma from patients with septicemia and other diseases. | Lipids | 1991 | https://conductscience.org/library/papers/1819737 | PubMed |
| 1537601 | Inactivation of platelet-activating factor by a putative acetylhydrolase from the gastrointestinal nematode parasite Nippostrongylus brasiliensis. | Immunology | 1992 | https://conductscience.org/library/papers/1537601 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PCLAF | 9768 | PubTator's text mining | https://conductscience.org/library/genes/9768 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2805409
GET https://conductscience.org/api/papers/v1/2805409/references?page=2